Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Yentz

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer Immunology, Immunotherapy : CII|October 5, 2024
Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 eraAllison L Gradone, Vincent T Ma, Alexi Vasbinder, et al.
Clinical Diabetes and Endocrinology|January 30, 2019
Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reportsMeng H Tan, Ravi Iyengar, Kara Mizokami-Stout, et al.
Lung Cancer (Amsterdam, Netherlands)|December 13, 2021
Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancerAlex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.
The Prostate|December 20, 2016
Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate CancerAjjai Alva, Luke Nordquist, Stephanie Daignault, et al.
The Journal of Urology|November 1, 2022
A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial CancerIrene Tsung, Edward Green, Phillip Palmbos, et al.
Frontiers in Oncology|August 28, 2020
Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient DataFrancesco Giovinazzo, Fiammetta Soggiu, Jin-Young Jang, et al.
JCO Precision Oncology|September 16, 2025
Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP)Irene Tsung, David C Smith, Elisabeth I Heath, et al.
JACC. Cardiooncology|January 13, 2023
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced MyocarditisAlexi Vasbinder, YeeAnn Chen, Adrien Procureur, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Immunology, Immunotherapy : CII|October 5, 2024
Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 eraAllison L Gradone, Vincent T Ma, Alexi Vasbinder, et al.
Clinical Diabetes and Endocrinology|January 30, 2019
Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reportsMeng H Tan, Ravi Iyengar, Kara Mizokami-Stout, et al.
Lung Cancer (Amsterdam, Netherlands)|December 13, 2021
Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancerAlex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.
The Prostate|December 20, 2016
Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate CancerAjjai Alva, Luke Nordquist, Stephanie Daignault, et al.
The Journal of Urology|November 1, 2022
A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial CancerIrene Tsung, Edward Green, Phillip Palmbos, et al.
Frontiers in Oncology|August 28, 2020
Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient DataFrancesco Giovinazzo, Fiammetta Soggiu, Jin-Young Jang, et al.
JCO Precision Oncology|September 16, 2025
Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP)Irene Tsung, David C Smith, Elisabeth I Heath, et al.
JACC. Cardiooncology|January 13, 2023
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced MyocarditisAlexi Vasbinder, YeeAnn Chen, Adrien Procureur, et al.
Pageof 2